Skip to content

Picosecond Nd: YAG1064nm laser in the treatment of melasma: a randomized controlled trial

Picosecond Nd: YAG1064nm laser in the treatment of melasma: a randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000031357
Enrollment
Unknown
Registered
2020-03-28
Start date
2020-03-18
Completion date
Unknown
Last updated
2020-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Melasma

Interventions

Group 1:1 time of treatment
Group 2:twice of treatment
Group 3:4 times of treatment

Sponsors

Huang Lvping
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Adults between the ages of 18 and 50 years; 2. Patients who are diagnosed as chloasma; 3. Patients who voluntarily participated in the study and signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Women in pregnancy or lactation; 2. Patients with a history of Photosensitivity; 3. With histories of any light, laser or ultrasound therapy in 1 year; 4. With histories of any treatments of melasma (including: tranexamic acid, isotretinoin, topical use of steroid or hydroquinone and etc.) in 1 year.

Design outcomes

Primary

MeasureTime frame
the modified melasma area and severity index (mMASI);

Secondary

MeasureTime frame
satisfaction questionnaire;

Countries

China

Contacts

Public ContactHuang Lvping

Plastic Surgery Hospital, Chinese Academy of Medical Sciences

414700347@qq.com+86 010-85557900

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026